Overview 

The US Preventive Services Task Force (USPSTF) is an independent panel of nationally recognized experts in prevention and evidence-based medicine that develops recommendations for clinical preventive services delivered in primary care settings. USPSTF recommendations influence clinical practice guidelines, preventive care quality initiatives, and insurance coverage. Under the Affordable Care Act, most commercial health plans must cover preventive services receiving an A or B recommendation without patient cost sharing. 

Recent administrative developments, including multiple canceled Task Force meetings, early termination of Vice-Chair terms, and uncertainty surrounding future appointments, have created questions regarding the pace of recommendation development and the long-term direction of the Task Force. Although there has been no formal announcement indicating changes to USPSTF methodology or statutory authority, leadership transitions often present opportunities to revisit priorities, membership composition, and evidence review processes. 

Current Status 

Per the USPSTF’s procedure manual, the Task Force is meant to meet three times a year (March, July, and November). However, it has not met since March 2025. Most recently, the July 2026 meeting was postponed until late August.  

The meeting cancellations coincide with broader leadership and organizational changes across the Department of Health and Human Services (HHS), raising questions about the timing of future member appointments, the continuity of the Task Force’s evidence review process, and the pace of future recommendation development. The Task Force has not released any recommendation updates since August 2025. Although existing recommendations remain in effect and evidence reviews continue, these disruptions could delay updates to current recommendations and consideration of new topics for preventive services recommendations.  

In April, Agency for Healthcare Research and Quality (AHRQ) posted a call for new member nominations with appointments to start in June. As June passed without new member announcements, HHS stated that it needed additional time to review, appoint, and onboard new Task Force members, and delayed the summer meeting to August.  

This timing deviates from the previous USPSTF member appointment timelines, where nominations for new members were due March 15th for terms that start the following January. Chairs and Vice-Chairs were previously announced by March. With several Task Force members’ terms completed in December 2025, and the termination of the two Vice-Chairs’ terms, it is uncertain how many new Task Force members will be appointed. Multiple individuals and organizations have released statements and letters regarding the impeding changes, including former Task Force chairs, 19 senators, American Medical Association, Friends of AHRQ with 104 health organizations, 60 cancer patient and provider organizations, 6 physician medical organizations, American Osteopathic Association, HIV Medicine Association, and 16 state nurses’ associations. 

While HHS has not announced changes to the USPSTF’s methodology or governance, the areas highlighted in Figure 1 identify key questions that Avalere Health will be focused on answering as the future direction of the Task Force becomes clearer. 

Figure 1. Key Questions Surrounding the Future of the USPSTF 

Historical Profile of USPSTF Members 

Historically, HHS has appointed nationally recognized experts to four-year terms on the Task Force, drawing from diverse clinical specialties and methodological disciplines relevant to preventive care. 

Typical nominees have expertise in primary and preventive care-related specialties or scientific areas of study, such as: 

• Family medicine  

• Internal medicine  

• Pediatrics  

• Obstetrics and gynecology  

• Nursing  

• Behavioral health  

• Population health  

• Epidemiology  

• Health services research  

• Evidence synthesis  

• Clinical decision science  

In addition to their clinical backgrounds, past members brought extensive experience in evidence-based medicine, systematic review methodology, clinical guideline development, population health, implementation science, academic research, and the evaluation of preventive interventions. 

The Task Force has historically balanced geographic, disciplinary, and demographic diversity with strong expertise in evidence evaluation and preventive medicine. Upcoming appointments will provide an indication of whether HHS intends to preserve this balance or shift the balance of expertise in different directions. 

Potential Implications for Healthcare Stakeholders 

Until HHS provides additional clarity, organizations should monitor developments that could affect: 

• Recommendation development timelines 

• Updates to existing preventive service recommendations 

• Topic prioritization 

• Public comment and stakeholder engagement opportunities 

• Evidence expectations for future preventive interventions 

Organizations developing diagnostics, therapeutics, medical technologies, and digital health solutions should continue building evidence strategies that align with the USPSTF’s current methodological standards while remaining prepared to adapt if future policy or process changes emerge. 

How Avalere Health Helps Clients Like You 

Avalere Health helps life sciences companies, health plans, advocacy organizations, and providers anticipate changes in the preventive care landscape by monitoring USPSTF policy developments, evaluating implications for evidence strategy, and identifying opportunities for stakeholder engagement. 

Our multidisciplinary USPSTF experts can partner with you to develop and implement a comprehensive strategy by: 

• Monitoring USPSTF governance and policy developments, including profiles of newly announced members 

• Assessing readiness for future USPSTF engagement  

• Identifying evidence gaps relative to USPSTF standards  

• Developing evidence generation strategies aligned with preventive care recommendations  

• Evaluating implications for coverage, reimbursement, and market access  

• Convening key stakeholders and building advocacy coalitions throughout the recommendation lifecycle  

Next Steps 

While existing USPSTF recommendations remain in effect, upcoming announcements regarding new member nominations, methodological approaches, and stakeholder engagement processes may provide important signals about the future direction of preventive care policy in the United States. 

Avalere Health is uniquely positioned to help organizations navigate this evolving landscape. With deep expertise across evidence generation, regulatory strategy, public policy, and quality frameworks, we offer a cross-functional approach tailored to the complexities of preventive care and USPSTF engagement. Our team helps diagnostic, biopharmaceutical, medical technology, and digital health innovators assess potential impacts of policy changes, identify evidence gaps, develop strategies aligned with USPSTF expectations, and prepare for future stakeholder engagement opportunities.  

As the preventive care landscape continues to evolve, Avalere Health can help organizations anticipate changes, mitigate risk, and position their innovations to support future recommendation development, coverage, and adoption. To learn more about how Avalere Health can assist you connect with us.